Traws Pharma (STU:0T20) Shares Buyback Ratio % : -334.64 (As of May. 12, 2025)

View and export this data going back to 2013. Start your Free Trial

What is Traws Pharma Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Traws Pharma's current shares buyback ratio was -334.64%.

Traws Pharma Shares Buyback Ratio % Historical Data

The historical data trend for Traws Pharma's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Traws Pharma Shares Buyback Ratio % Chart

Traws Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Shares Buyback Ratio %

Get a 7-Day Free Trial

-67.57

-68.55

-0.12

-0.36

-334.64

Traws Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-0.36	-20.05	-199.01	-20.65

Traws Pharma Shares Buyback Ratio % Calculation

Traws Pharma's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(0.840	-	3.651)	/	0.840
	=	-334.64%

Traws Pharma's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Sep. 2024 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Sep. 2024 )
	=	(3.026	-	3.651)	/	3.026
	=	-20.65%

Traws Pharma Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Traws Pharma's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Traws Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Traws Pharma Inc (STU:0T20) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

TRAW:USA

Address

12 Penns Trail, Newtown, PA, USA, 18940

Website

https://www.trawspharma.com

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

Traws Pharma Headlines

No Headlines